Zobrazeno 1 - 10
of 296
pro vyhledávání: '"Te Sheng Chang"'
Autor:
Ching-Chu Lo, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Chi-Yi Chen, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Chun-Yen Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Te Sheng Chang, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Wan-Long Chuang, Han-Chieh Lin, Jia-Horng Kao, Ming-Lung Yu
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 8, Pp 1567-1578 (2022)
Background/purpose: The Taiwan Association for the Study of the Liver (TASL) HCV Registry (TACR) is a nationwide registry of chronic hepatitis C patients in Taiwan. This study evaluated antiviral effectiveness of ledipasvir (LDV)/sofosbuvir (SOF) in
Externí odkaz:
https://doaj.org/article/e3fc588ffb4644ea879b1c65ce5709a5
Autor:
Yuan-Jie Ding, Te-Sheng Chang, Chien-Heng Shen, Liang-Mou Kuo, Sheng-Lung Hsu, Yi-Hsing Chen, Yung-Yu Hsieh, Hui-Ling Huang, Sheng-Nan Lu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract To clarify the survival benefit of sequential curative treatment post transcatheter arterial chemoembolization (TACE) for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC), we retrospectively analyzed HCC patients a
Externí odkaz:
https://doaj.org/article/02f701ef1a0d4cdabe8661ebc17b8386
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 6, Pp 589-598 (2024)
Abstract In 2008, sorafenib became the first approved systemic therapeutic agent for advanced HCC. Although its pharmacological efficacy has been established, reimbursement for such a new, high‐cost drug, as well as physicians' awareness and prescr
Externí odkaz:
https://doaj.org/article/f7774ca97ae34dc3a020f61eb904b4ac
Autor:
Chien-Hung Chen, Nien-Tzu Hsu, I-Chun Chen, Te-Sheng Chang, Shing Cheng, Shi-Yann Cheng, Hung-Ming Chen, Ming-Rong Harn, Chen-Kou Liu, Mao-Ting Yang, Shih-Lung Lu, Chun-Mei Tseng, Sheng-Nan Lu
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 5, Pp 613-619 (2024)
Background: /Purpose: To achieve the World Health Organization goal of eliminating viral hepatitis by 2030, a key strategy in resource-limited areas is to identify the areas with high prevalence and to prioritize screening and treatment intervention.
Externí odkaz:
https://doaj.org/article/3ba0df8e04124893b7caa11e3fb14516
Autor:
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Hsing-Tao Kuo, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Ming-Lung Yu
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1199-1213 (2024)
Abstract Introduction Eight-week glecaprevir/pibrentasvir (GLE/PIB) is indicated for treatment-naïve (TN) patients with chronic hepatitis C (CHC), with or without compensated cirrhosis. Given that the Taiwanese government is committed to eliminating
Externí odkaz:
https://doaj.org/article/14215fa1ee784d7ab2393d1356d5db36
Autor:
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih‐Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Cheng-Yuan Peng, Chun-Wei- Tsai, Chi-Yi Chen, Ming-Lung Yu
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 1, Pp 64-79 (2024)
Background/Aims Despite the high efficacy of direct-acting antivirals (DAAs), approximately 1–3% of hepatitis C virus (HCV) patients fail to achieve a sustained virological response. We conducted a nationwide study to investigate risk factors assoc
Externí odkaz:
https://doaj.org/article/29b467adfe714190932d96e188f51734
Publikováno v:
Journal of Research in Education Sciences, Vol 68, Iss 4, Pp 95-127 (2023)
臺灣於2019年5月24日正式成為亞洲第一個同性結婚合法化的國家,揆諸現況,相較於其他年齡群體,高齡者對於同志結婚和成家撫養小孩的反對意見最為強烈。本研究試圖對高齡者進行同志結
Externí odkaz:
https://doaj.org/article/77e7b96bcac34f59913c54f5763745e2
Publikováno v:
Journal of Research in Education Sciences, Vol 67, Iss 3, Pp 147-176 (2022)
本研究旨在探討大學生在大學四年之教育抱負與職業抱負的改變情形,並分析性別與就讀領域對這兩種抱負影響的情形。本研究以1,090位大學生為對象,以四次的自填式問卷為工具,持續追
Externí odkaz:
https://doaj.org/article/569b4347a5434a569534b4dfa485a8e6
Autor:
Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Chien-Heng Shen, Kuo-Liang Wei, Kao-Chi Chang, Yuan-Jie Ding, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Publikováno v:
Diagnostics, Vol 14, Iss 2, p 213 (2024)
Few studies have reported weight gain in patients with hepatitis C virus (HCV) infection treated with direct-acting antiviral agents (DAAs). This retrospective cohort study identified factors associated with substantial weight gain after DAA treatmen
Externí odkaz:
https://doaj.org/article/33b5deec26a54961acb36f5de2e5ac2f
Autor:
Te Sheng Chang, 張德生
103
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer mortality worldwide. Surgical resection is considered curative for patients with an early stage HCC, but high rate of tumor recurrence remai
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer mortality worldwide. Surgical resection is considered curative for patients with an early stage HCC, but high rate of tumor recurrence remai
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/72384344933860613476